Glucosylated Epigallocatechin Gallate (EGCG) Derivatives Combined with EGFR Tyrosine Kinase Inhibitor Overcome Resistance in EGFR T790M Mutant Lung Cancer

Jing Wang, Yu-Na Wang, Pei-Yuan Sun, Cheng-Ting Zi, Xuan-Jun Wang, Jun Sheng, Cheng-Ting Zi, Xuan-Jun Wang, Jing Wang, Yu-Na Wang, Pei-Yuan Sun and Jun Sheng
Additional contact information
Jun Sheng: Key Laboratory of Pu-er Tea Science, Ministry of Education, China
Xuan-Jun Wang: College of Science, Yunnan Agricultural University, China
Jun Sheng: College of Food Science and Technology, Yunnan Agricultural University, China

Biomedical Journal of Scientific & Technical Research, 2019, vol. 18, issue 2, 13474-13479

Abstract: EGFR tyrosine kinase inhibitors (TKIs) gefitinib and erlotinib are approved treatments for non-small cell lung cancers harboring activating mutation...

Keywords: Biomedical Sciences; Biomedical Research; Technical Research; EGCG; Glycosides; NSCLC; EGFR TKIs; Combination (search for similar items in EconPapers)
Date: 2019
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.003133.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.003133.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:18:y:2019:i:2:p:13474-13479

DOI: 10.26717/BJSTR.2019.18.003133

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().